Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem.

[1]  William H. Oldendorf,et al.  [3H]Tryptamine and 3H-water as diffusible internal standards for measuring brain extraction of radio-labeled substances following carotid injection , 1976, Brain Research.

[2]  K. Lloyd,et al.  Specificity within the GABAA receptor supramolecular complex: A consideration of the new ω 1-receptor selective imidazopyridine hypnotic zolpidem , 1988, Pharmacology Biochemistry and Behavior.

[3]  V. Ascalone,et al.  Determination of alpidem and its metabolites in human plasma by high-performance liquid chromatography and fluorimetric detection. , 1987, Journal of chromatography.

[4]  G. Biggio,et al.  Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors. , 1990, European journal of pharmacology.

[5]  P. Benfield,et al.  Zolpidem , 1990, Drugs.

[6]  D. Wheatley.  Use of anti-anxiety drugs in the medically ill. , 1988, Psychotherapy and psychosomatics.

[7]  J. E. Goodrich,et al.  Opioid receptor subtype-specific cross-tolerance to the effects of morphine on schedule-controlled behavior in mice , 2004, Psychopharmacology.

[8]  A. Nicholson,et al.  Hypnotic activity of an imidazo-pyridine (zolpidem). , 1986, British journal of clinical pharmacology.

[9]  A. Nicholson.  Hypnotics , 1986, Drugs.

[10]  P. Hermann,et al.  High-performance liquid chromatographic determination of zolpidem, a new sleep inducer, in biological fluids with fluorimetric detection. , 1986, Journal of chromatography.

[11]  M. Lader,et al.  Studies with alpidem in normal volunteers and anxious patients. , 1990, Pharmacopsychiatry.

[12]  G. Perrault,et al.  Pharmacological and Behavioral Profile of Alpidem as an Anxiolytic , 1990, Pharmacopsychiatry.

[13]  K. Lloyd,et al.  Selectivity for Omega-Receptor Subtypes as a Strategy for the Development of Anxiolytic Drugs , 1990, Pharmacopsychiatry.

[14]  P. Morselli,et al.  Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat. , 1989, The Journal of pharmacology and experimental therapeutics.

[15]  S. Z. Langer,et al.  LIMITATIONS OF THE BENZODIAZEPINE RECEPTOR NOMENCLATURE: A PROPOSAL FOR A PHARMACOLOGICAL CLASSIFICATION AS OMEGA RECEPTOR SUBTYPES , 1988, Fundamental & clinical pharmacology.

[16]  S. Z. Langer,et al.  Imidazopyridines as a tool for the characterization of benzodiazepine receptors: A proposal for a pharmacological classification as omega receptor subtypes , 1988, Pharmacology Biochemistry and Behavior.

[17]  G. Bianchetti,et al.  Plasma protein binding of alpidem in healthy volunteers, in neonates and in liver or renal insufficiency , 2004, European Journal of Clinical Pharmacology.